150 related articles for article (PubMed ID: 35081385)
1. Mucocutaneous Xanthodermatosis as Initial Presentation of Immunoglobulin Light Chain Amyloidosis.
da Fonseca AM; Furlan BB; Irffi GP; de Oliveira GB; Souza EG; Rezende SM
Am J Med; 2022 Jun; 135(6):724-727. PubMed ID: 35081385
[No Abstract] [Full Text] [Related]
2. Intraoral hemorrhagic bullae as the first sign of immunoglobulin light chain amyloidosis.
Dominguez-Lopez RM; Naharro-Rodriguez J
CMAJ; 2024 May; 196(20):E705. PubMed ID: 38802132
[No Abstract] [Full Text] [Related]
3. Systemic amyloidosis presented with leonine facies.
Liu JW; Tan Y; Chen T; Qian YT; Ma DL
QJM; 2024 Apr; 117(4):287-288. PubMed ID: 38060280
[No Abstract] [Full Text] [Related]
4. Perioral skin thickening revealing AL amyloidosis.
Billard K; Arnulf B; Kottler D; Mirouse A; Harel S; Royer B; Bagot M; Jachiet M; Bouaziz JD; Mahévas T;
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e703-e705. PubMed ID: 35445455
[No Abstract] [Full Text] [Related]
5. Reversing the poor prognosis of primary amyloid light‑chain amyloidosis with cardiac involvement.
Jurczyszyn A; Rajtar-Salwa R; Sorysz D; Zawiślak B; Suska A; Szostek M
Pol Arch Intern Med; 2022 Apr; 132(4):. PubMed ID: 35076194
[No Abstract] [Full Text] [Related]
6. Systemic Light Chain Amyloidosis.
Sanchorawala V
N Engl J Med; 2024 Jun; 390(24):2295-2307. PubMed ID: 38924733
[No Abstract] [Full Text] [Related]
7. Mucocutaneous manifestations of systemic amyloidosis in a Black patient.
Ramachandran V
QJM; 2022 Apr; 115(4):237-238. PubMed ID: 35179575
[No Abstract] [Full Text] [Related]
8. Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency.
Guo YM; Takahashi N; Miyabe K; Yoshida M; Abe F; Yamashita T; Nara M; Yoshioka T; Ohashi K; Goto A; Takahashi N
Intern Med; 2019 Oct; 58(20):3039-3043. PubMed ID: 31243220
[TBL] [Abstract][Full Text] [Related]
9. [A case of lambda-light chain type primary amyloidosis with abdominal pain as the initial manifestation].
Yang MY; Fu XL; Yang YF; Chang JB
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):328-330. PubMed ID: 35462492
[TBL] [Abstract][Full Text] [Related]
10. Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis.
Ravichandran S; Law S; Mahmood S; Wisniowski B; Foard D; Fontana M; Martinez-Naharro A; Whelan C; Gillmore JD; Lachmann HJ; Hawkins PN; Wechalekar AD
Leukemia; 2022 Apr; 36(4):1180-1184. PubMed ID: 34987193
[No Abstract] [Full Text] [Related]
11. Systemic amyloidosis in a patient presenting with myopathy, peripheral oedema and proteinuria.
Bywater L; Gist AC; Muthalaly RG; Loh J; Simpson I; White AJ; Lim AK
Med J Aust; 2022 Sep; 217(5):232-234. PubMed ID: 35924379
[No Abstract] [Full Text] [Related]
12. Long standing polyneuropathy as a form of presentation of primary systemic amyloidosis.
Jiménez Caballero PE
Neurologia; 2012 Sep; 27(7):447-8. PubMed ID: 22217524
[No Abstract] [Full Text] [Related]
13. Gastroparesis: an under-recognised manifestation of systemic amyloidosis.
Abdullah KM; Alsuraimi A; Kagbo-Kue S; Vela M
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37130641
[TBL] [Abstract][Full Text] [Related]
14. Macroglossia Associated With Primary Systemic Amyloidosis - Case Report With Unusual Clinical Presentation.
Muniyan S; Nair Sreela LS; Mathew P; Prasad T; Nair AS; Jose M
J Ayub Med Coll Abbottabad; 2022; 34(1):197-199. PubMed ID: 35466653
[TBL] [Abstract][Full Text] [Related]
15. Severe Obstructive Cholestasis and Hypercalcemia Caused by Light-Chain Amyloidosis: A Case Report.
Davoudi Z; Bidari F; Jamali E; Nikpour S
Iran J Med Sci; 2022 Jan; 47(1):73-77. PubMed ID: 35017780
[TBL] [Abstract][Full Text] [Related]
16. Comments on COVID-19 and AL Amyloidosis, the Missing Links.
Jain A
Am J Med; 2022 Jun; 135(6):e137-e138. PubMed ID: 35623720
[No Abstract] [Full Text] [Related]
17. Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis.
Chyra Z; Sevcikova T; Vojta P; Puterova J; Brozova L; Growkova K; Filipova J; Zatopkova M; Grosicki S; Barchnicka A; Jedrzejczak WW; Waszczuk-Gajda A; Jungova A; Mikulasova A; Hajduch M; Mokrejs M; Pour L; Stork M; Harvanova L; Mistrik M; Mikala G; Robak P; Czyz A; Debski J; Usnarska-Zubkiewicz L; Jurczyszyn A; Stejskal L; Morgan G; Kryukov F; Budinska E; Simicek M; Jelinek T; Hrdinka M; Hajek R
Haematologica; 2021 Feb; 106(2):601-604. PubMed ID: 32381580
[No Abstract] [Full Text] [Related]
18. [AL amyloidosis, from diagnosis to treatment].
Villesuzanne C; Jaccard A; Nicol M
Rev Prat; 2020 Dec; 70(10):1137-1141. PubMed ID: 33739663
[TBL] [Abstract][Full Text] [Related]
19. AL-Kappa Primary Amyloidosis with Apolipoprotein A-IV Deposition.
Ishimitsu A; Tojo A; Hirao J; Yokoyama S; Ohira T; Murayama Y; Ishimitsu T; Kang D; Honda K; Ehara T; Ishida K; Ueda Y
Intern Med; 2022; 61(6):871-876. PubMed ID: 35296622
[TBL] [Abstract][Full Text] [Related]
20. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
Manabe S; Iwasaki C; Hatano M; Kametani F; Yazaki M; Nitta K; Nagata M
BMC Nephrol; 2018 Nov; 19(1):337. PubMed ID: 30466387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
